Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily) - Concepedia

Concepedia

Publication | Open Access

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

DOI Full Paper Access

18

Citations

17

References

2016

Year

Zhenxin Zhang, Zhen Hong, Yanping Wang, Li He, Ning Wang, Zhongxin Zhao, Gang Zhao, Lan Shang, Marianne Weisskopf, Francesca Callegari,

CNS Neuroscience & Therapeutics

Abstract

Rivastigmine patch 9.5 mg/24 h is effective and well tolerated in Chinese patients with probable AD.

References

	Year	Citations

Page 1